Works matching AU Limmroth, Volker


Results: 51
    1
    2
    3
    4
    5
    6
    7

    Pain Therapy in German Neurology.

    Published in:
    European Neurology, 2008, v. 60, n. 4, p. 167, doi. 10.1159/000148243
    By:
    • Gerbershagen, Kathrin;
    • Limmroth, Volker
    Publication type:
    Article
    8
    9
    10
    11
    12

    Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study.

    Published in:
    2020
    By:
    • Ziemssen, Tjalf;
    • Bass, Ann D.;
    • Berkovich, Regina;
    • Comi, Giancarlo;
    • Eichau, Sara;
    • Hobart, Jeremy;
    • Hunter, Samuel F;
    • LaGanke, Christopher;
    • Limmroth, Volker;
    • Pelletier, Daniel;
    • Pozzilli, Carlo;
    • Schippling, Sven;
    • Sousa, Livia;
    • Traboulsee, Anthony;
    • Uitdehaag, Bernard M. J.;
    • Van Wijmeersch, Bart;
    • Choudhry, Zia;
    • Daizadeh, Nadia;
    • Singer, Barry A.;
    • CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ investigators
    Publication type:
    journal article
    13
    14

    Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings.

    Published in:
    Frontiers in Neurology, 2019, p. N.PAG, doi. 10.3389/fneur.2019.00253
    By:
    • Barclay, Krista;
    • Carruthers, Robert;
    • Traboulsee, Anthony;
    • Bass, Ann D.;
    • LaGanke, Christopher;
    • Bertolotto, Antonio;
    • Boster, Aaron;
    • Celius, Elisabeth G.;
    • Seze, Jérôme de;
    • Cruz, Dionisio Dela;
    • Habek, Mario;
    • Lee, Jong-Mi;
    • Limmroth, Volker;
    • Meuth, Sven G.;
    • Oreja-Guevara, Celia;
    • Pagnotta, Patricia;
    • Vos, Cindy;
    • Ziemssen, Tjalf;
    • Baker, Darren P.;
    • Wijmeersch, Bart Van
    Publication type:
    Article
    15

    Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, n. 14, p. 1866, doi. 10.1177/1352458519888610
    By:
    • Comi, Giancarlo;
    • Alroughani, Raed;
    • Boster, Aaron L;
    • Bass, Ann D;
    • Berkovich, Regina;
    • Fernández, Óscar;
    • Kim, Ho Jin;
    • Limmroth, Volker;
    • Lycke, Jan;
    • Macdonell, Richard AL;
    • Sharrack, Basil;
    • Singer, Barry A;
    • Vermersch, Patrick;
    • Wiendl, Heinz;
    • Ziemssen, Tjalf;
    • Jacobs, Alan;
    • Daizadeh, Nadia;
    • Rodriguez, Claudio E;
    • Traboulsee, Anthony;
    • Baker, Darren P.
    Publication type:
    Article
    16

    Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.

    Published in:
    Multiple Sclerosis Journal, 2015, v. 21, n. 8, p. 1036, doi. 10.1177/1352458514556296
    By:
    • Warnke, Clemens;
    • Stettner, Mark;
    • Lehmensiek, Vera;
    • Dehmel, Thomas;
    • Mausberg, Anne K.;
    • Von Geldern, Gloria;
    • Gold, Ralf;
    • Kümpfel, Tania;
    • Hohlfeld, Reinhard;
    • Mäurer, Mathias;
    • Stangel, Martin;
    • Straeten, Vera;
    • Limmroth, Volker;
    • Weber, Thomas;
    • Kleinschnitz, Christoph;
    • Wattjes, Mike P.;
    • Svenningsson, Anders;
    • Olsson, Tomas;
    • Hartung, Hans-Peter;
    • Hermsen, Derik
    Publication type:
    Article
    17

    Anti-JC-virus antibody prevalence in a German MS cohort.

    Published in:
    2012
    By:
    • Warnke, Clemens;
    • Dehmel, Thomas;
    • Posevitz-Fejfár, Anita;
    • Chan, Andrew;
    • Berthele, Achim;
    • Schmidt, Stephan;
    • Haas, Judith;
    • Kronsbein, Helena C;
    • Seitz, Florian;
    • Tackenberg, Björn;
    • Mäurer, Mathias;
    • Gerbershagen, Kathrin;
    • Limmroth, Volker;
    • Adams, Ortwin;
    • Hartung, Hans-Peter;
    • Gold, Ralf;
    • Hemmer, Bernhard;
    • Wiendl, Heinz;
    • Kieseier, Bernd C
    Publication type:
    Letter
    18

    Effect of BG-12 on contrast-enhanced lesions in patients with relapsing– remitting multiple sclerosis: subgroup analyses from the phase 2b study.

    Published in:
    Multiple Sclerosis Journal, 2012, v. 18, n. 3, p. 314, doi. 10.1177/1352458511421054
    By:
    • Kappos, Ludwig;
    • Gold, Ralf;
    • Miller, David H;
    • MacManus, David G;
    • Havrdova, Eva;
    • Limmroth, Volker;
    • Polman, Chris H;
    • Schmierer, Klaus;
    • Yousry, Tarek A;
    • Eraksoy, Mefkure;
    • Meluzinova, Eva;
    • Dufek, Michal;
    • Yang, Minhua;
    • Dawson, Kate;
    • O’Neill, Gilmore N
    Publication type:
    Article
    19
    20
    21

    Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.

    Published in:
    Annals of Neurology, 2014, v. 76, n. 6, p. 792, doi. 10.1002/ana.24153
    By:
    • Warnke, Clemens;
    • Geldern, Gloria;
    • Markwerth, Philipp;
    • Dehmel, Thomas;
    • Hoepner, Robert;
    • Gold, Ralf;
    • Pawlita, Michael;
    • Kümpfel, Tania;
    • Mäurer, Mathias;
    • Stangel, Martin;
    • Wegner, Florian;
    • Hohlfeld, Reinhard;
    • Straeten, Vera;
    • Limmroth, Volker;
    • Weber, Thomas;
    • Hermsen, Derik;
    • Kleinschnitz, Christoph;
    • Hartung, Hans‐Peter;
    • Wattjes, Mike P.;
    • Svenningson, Anders
    Publication type:
    Article
    22

    (DMT02) Yearly Efficacy and Safety Outcomes Over 4 Years After Last Alemtuzumab Course in Pooled CAREMS I and II Patients by Number of Additional Courses Received Through Year 9.

    Published in:
    International Journal of MS Care, 2020, v. 22, n. S2, p. 4
    By:
    • Berkovich, Regina;
    • Alroughani, Raed;
    • Bass, Ann D.;
    • Boster, Aaron L.;
    • Comi, Giancarlo;
    • Ho Jin Kim;
    • Limmroth, Volker;
    • Lycke, Jan;
    • Macdonell, Richard A. L.;
    • Schippling, Sven;
    • Sharrack, Basil;
    • Tintoré, Mar;
    • Traboulsee, Anthony;
    • Vermersch, Patrick;
    • Wiendl, Heinz;
    • Ziemssen, Tjalf;
    • Daizadeh, Nadia;
    • Jacobs, Alan;
    • Poole, Elizabeth M.;
    • Singer, Barry A.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation.

    Published in:
    Journal of Neurology, 2019, v. 266, n. 1, p. 165, doi. 10.1007/s00415-018-9117-z
    By:
    • Pfeuffer, Steffen;
    • Schmidt, Rene;
    • Straeten, Frederike Anne;
    • Pul, Refik;
    • Kleinschnitz, Christoph;
    • Wieshuber, Marinus;
    • Lee, De-Hyung;
    • Linker, Ralf A.;
    • Doerck, Sebastian;
    • Straeten, Vera;
    • Windhagen, Susanne;
    • Pawlitzki, Marc;
    • Aufenberg, Christoph;
    • Lang, Michael;
    • Eienbroeker, Christian;
    • Tackenberg, Björn;
    • Limmroth, Volker;
    • Wildemann, Brigitte;
    • Haas, Jürgen;
    • Klotz, Luisa
    Publication type:
    Article
    42

    Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study.

    Published in:
    Journal of Neurology, 2018, v. 265, n. 7, p. 1521, doi. 10.1007/s00415-018-8871-2
    By:
    • Huhn, Konstantin;
    • Bayas, Antonios;
    • Doerck, Sebastian;
    • Frank, Benedikt;
    • Gerbershagen, Kathrin;
    • Hellwig, Kerstin;
    • Kallmann, Boris;
    • Kleinschnitz, Christoph;
    • Kleiter, Ingo;
    • Lee, De-Hyung;
    • Limmroth, Volker;
    • Mäurer, Mathias;
    • Meuth, Sven;
    • Rieckmann, Peter;
    • Ruck, Tobias;
    • Gold, Ralf;
    • Linker, Ralf A.
    Publication type:
    Article
    43

    Quality Assessment in Multiple Sclerosis Therapy (QUASIMS).

    Published in:
    Journal of Neurology, 2007, v. 254, n. 1, p. 67, doi. 10.1007/s00415-006-0281-1
    By:
    • Limmroth, Volker;
    • Malessa, Rolf;
    • Zettl, Uwe Klaus;
    • Koehler, Jürgen;
    • Japp, Gudrun;
    • Haller, Peter;
    • Elias, Wolfgang;
    • Obhof, Winfried;
    • Viehöver, Andrea;
    • Meier, Uwe;
    • Brosig, Arne;
    • Hasford, Joerg;
    • Putzki, Norman;
    • Kalski, Gabriele;
    • Wernsdörfer, Colin
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50